Protective Effects of Carvedilol in Murine Model With the Coxsackievirus B3-Induced Viral Myocarditis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2008-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/FJC.0b013e31815c6624PMID 18209574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of α1-adrenergic receptors in cardiac pathophysiology

  2006cited by this paper
• Effect of alpha1-adrenergic receptors in cardiac pathophysiology.

  2006cited by this paper
• Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure.

  2005cited by this paper
• Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis.

  2005cited by this paper
• The pharmacology of carvedilol

  2005cited by this paper
• Carvedilol improves left ventricular function in murine coxsackievirus‐induced acute myocarditis Association with reduced myocardial interleukin‐1β and MMP‐8 expression and a modulated immune response

  2005cited by this paper
• Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.

  2004cited by this paper
• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

  2003cited by this paper
• Direct interferon-γ-mediated protection caused by a recombinant coxsackievirus B3

  2003cited by this paper
• Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.

  2003cited by this paper
• Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.

  2003cited by this paper
• Cardioprotective effects of carvedilol on acute autoimmune myocarditis.

  2003cited by this paper
• Long-Term Effects of Carvedilol on Left Ventricular Function, Remodeling, and Expression of Cardiac Cytokines After Large Myocardial Infarction in the Rat

  2002cited by this paper
• Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy.

  2002cited by this paper
• Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha.

  2001cited by this paper
• Antioxidant vitamins prevent cardiomyocyte apoptosis produced by norepinephrine infusion in ferrets.

  2001cited by this paper
• Fulminant coxsackieviral myocarditis.

  2001cited by this paper
• Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids.

  2000cited by this paper
• Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

  2000cited by this paper
• Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

  2000cited by this paper
• Nadolol inhibits reactive oxygen species generation by leukocytes and linoleic acid oxidation.

  2000cited by this paper
• Regulation of gene expression by reactive oxygen.

  1999cited by this paper
• Effect of (cid:98) -Blockers on Free Radical–Induced Cardiac Contractile Dysfunction

  1999cited by this paper
• Effect of beta-blockers on free radical-induced cardiac contractile dysfunction.

  1999cited by this paper
• Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure.

  1999cited by this paper
• Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.

  1998cited by this paper
• CARVEDILOL UPDATE IV : PREVENTION OF OXIDATIVE STRESS, CARDIAC REMODELING AND PROGRESSION OF CONGESTIVE HEART FAILURE

  1997cited by this paper
• Cardiac microdialysis of salicylic acid .OH generation on nonenzymatic oxidation by norepinephrine in rat heart.

  1997cited by this paper
• Protective role of interleukin-12 in viral myocarditis.

  1997cited by this paper
• Oxidized low density lipoproteins impair peripheral blood mononuclear cell proliferation and cytokine production.

  1997cited by this paper
• Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

  1997cited by this paper
• Inhibition of gamma interferon synthesis by catecholamines.

  1997cited by this paper
• Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects.

  1995cited by this paper
• Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.

  1993cited by this paper
• Effect of Enalapril, Hydralazine Plus Isosorbide Dinitrate, and Prazosin on Hospitalization in Patients With Chronic Congestive Heart Failure

  1993cited by this paper
• Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.

  1992cited by this paper
• Carvedilol: A Novel Cardiovascular Drug with Multiple Actions

  1992cited by this paper
• β‐Blocker Treatment of Dilated Cardiomyopathy: Beneficial Effect of Carteolol in Mice

  1991cited by this paper
• Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

  1991cited by this paper
• Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.

  1988cited by this paper
• Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.

  1988cited by this paper
• Pharmacological Profile of Carvedilol as a β-Blocking Agent with Vasodilating and Hypotensive Properties

  1987cited by this paper
• Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease.

  1983cited by this paper
• Comparison of pre- and postsynaptic alpha-adrenoceptor blocking effects of E-643 in the isolated vas deferens of the rat.

  1981cited by this paper

• Vagus nerve plays a pivotal role in CD4+ T cell differentiation during CVB3-induced murine acute myocarditis

  2020cites this paper
• Therapies to limit myocardial injury in animal models of myocarditis: a systematic review and meta-analysis

  2019cites this paper
• Myopericarditis with preserved left ventricular function secondary to Neisseria meningitidis.

  2018cites this paper
• The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4+ T cell differentiation

  2018cites this paper
• Right Cervical Vagotomy Aggravates Viral Myocarditis in Mice Via the Cholinergic Anti-inflammatory Pathway

  2017cites this paper
• Carvedilol can attenuate histamine‐induced paw edema and formaldehyde‐induced arthritis in rats without risk of gastric irritation

  2017cites this paper
• Recent Advances in Management of Myocarditis.

  2016cites this paper
• Nicotine inhibits the production of proinflammatory cytokines of mice infected with coxsackievirus B3.

  2016cites this paper
• Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy.

  2016cites this paper
• Oxidative stress and myocarditis.

  2016cites this paper
• Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3

  2015cites this paper
• Erratum: Dose-dependent protective effect of nicotine in a murine model of viral myocarditis induced by coxsackievirus B3

  2015cites this paper
• Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: modulation of oxidative stress and inflammatory mediators.

  2013cites this paper
• Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.

  2013cites this paper
• EVIEW anagement of pericarditis and yocarditis : Could heart-rate-reducing rugs hold a promise ? rise en charge des péricardites et myocardites : les médicaments radycardisants sont-ils prometteurs ?

  2013cites this paper
• Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis

  2013cites this paper
• Management of pericarditis and myocarditis: could heart-rate-reducing drugs hold a promise?

  2013cites this paper
• Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis

  2013cites this paper
• The mechanism of carvedilol in experimental viral myocarditis.

  2012cites this paper
• Comparison of Effects of Ivabradine versus Carvedilol in Murine Model with the Coxsackievirus B3-Induced Viral Myocarditis

  2012cites this paper
• Chapter 31 – Heart Failure as a Consequence of Viral and Nonviral Myocarditis

  2011cites this paper
• A fluorescence resonance energy transfer-based fluorometer assay for screening anti-coxsackievirus B3 compounds.

  2011cites this paper
• fluorescence resonance energy transfer-based fluorometer ssay for screening anti-coxsackievirus B 3 compounds ason

  2010influential citation
• Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.

  2010cites this paper
• Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.

  2010cites this paper
• Cardioprotective effect of NO‐metoprolol in murine coxsackievirus B3‐induced myocarditis

  2010cites this paper
• Distinctive Effects of Carvedilol in the Non-Infarct Zone: Remodelling of the Ligated Rat Heart Linked to Oxidative Stress

  2009cites this paper
• New Perspectives of Infections in Cardiovascular Disease

  2009cites this paper
• The dual role of the cystathionine gamma-lyase/hydrogen sulfide pathway in CVB3-induced myocarditis in mice.

  2009cites this paper
• ' s response to reviews Title : Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B 3-induced myocarditis

  year unknowncites this paper